NasdaqCM - Nasdaq Real Time Price USD
Benitec Biopharma Inc. (BNTC)
16.91
+0.74
+(4.56%)
As of 10:41:54 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 5 | 7 | 7 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.49 | -0.55 | -0.78 | -0.35 |
| EPS Actual | -- | -0.48 | -0.33 | -0.24 |
| Difference | -- | 0.07 | 0.45 | 0.11 |
| Surprise % | -- | 12.73% | 57.46% | 31.10% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BNTC | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/19/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 5/15/2025 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 4/10/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/24/2025 |
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 3/18/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/21/2025 |
Related Tickers
SOFTX.OL SoftOx Solutions AS
0.0782
-3.46%
NANECH.ST NanoEcho AB
0.0898
-11.26%
LSW.F Tissue Regenix Group plc
0.3320
+1.84%
MOLNz.XC
PYC.AX PYC Therapeutics Limited
1.2050
+0.42%
SQZB SQZ Biotechnologies Company
0.0390
+30.00%
UPB Upstream Bio, Inc.
11.50
+1.86%
ONCO.ST Oncopeptides AB (publ)
1.5580
+2.77%
SLNO Soleno Therapeutics, Inc.
79.13
+1.79%
ACLX Arcellx, Inc.
66.99
+0.19%